ETF Copies Hedgies,...
Health Care: Drugs
Pfizer Inc (PFE: NYSE)
$28.78 0.08 | 0.28%
05/21/13 - 04:01 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 14.60B | 10.05B | 8.29B | 8.64B |
| Operating Gains/Losses | -7.12B | -1.67B | -155.00M | -602.00M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 275.00M | -66.00M | -608.00M | -472.00M |
| (Increase) Decrease in Inventories | -631.00M | 1.08B | 2.92B | 1.63B |
| (Increase) Decrease In Other Current Assets | 83.00M | 582.00M | -896.00M | -867.00M |
| (Decrease) Increase In Payables | 579.00M | 1.15B | 827.00M | 1.70B |
| (Decrease) Increase In Other Current Liabilities | -2.25B | -18.00M | -12.67B | 10.53B |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 1.71B | -83.00M | 3.31B | 853.00M |
| Net Cash From Continuing Operations | 17.05B | 20.24B | 11.45B | 16.59B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 17.05B | 20.24B | 11.45B | 16.59B |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 25.30B | 25.05B | 10.49B | 48.14B |
| Purchases of Property, Plant & Equipment | -1.33B | -1.66B | -1.51B | -1.20B |
| Acquisitions | 10.80B | -906.00M | -273.00M | -43.12B |
| Purchases of Short-Term Investments | -24.02B | -18.43B | -10.93B | -35.33B |
| Other Cash from Investing Activities | 1.55B | 60.00M | 1.27B | 632.00M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 6.15B | 2.20B | -492.00M | -31.27B |
| Issuance of Debt | 8.00B | 12.81B | 6.40B | 56.06B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Repayment of Long-Term Debt | -1.52B | -10.81B | -10.55B | -35.94B |
| Repurchase of Capital Stock | -8.23B | -9.00B | -1.00B | 0.00 |
| Payment of Cash Dividends | -6.53B | -6.23B | -6.09B | -5.55B |
| Other Financing Charges, Net | -7.72B | -7.37B | 66.00M | -91.00M |
| Net Cash From Financing Activities | -16.00B | -20.61B | -11.17B | 14.48B |
| Effect of Exchange Rate Changes | -2.00M | -29.00M | -31.00M | 60.00M |
| Net Change in Cash & Cash Equivalents | 7.21B | 1.80B | -243.00M | -144.00M |
Portfolios with PFE
- Portfolio NameUser Type
- Userdennis diamonds
- Userchrisnash69 Portfolio 1
- Userdennis all star
- UserBUYS
- UserThe Best Dividend Stocks
- ContributorHigh Volume Technicals for ...
- ContributorHigh Volume Technicals for ...
- UserFitz.ColinGerald
- ContributorHigh Volume Technicals for ...
- ContributorDividend Stocks for the Wee...
Latest PFE Headlines from TheStreet
- Pfizer Reaches New 52-Week High (PFE) 04.19.13 | 04:04 pm
- This Rally Is in Make-or-Break Mode: 5 Must-See Charts 04.18.13 | 12:04 pm
- 5 Stocks Pulling The Health Care Sector Downward 04.17.13 | 01:04 pm
- Pfizer Inc Stock Buy Recommendation Reiterated (PFE) 04.16.13 | 10:04 am
- 'Mad Money' Uncovered: Big Pharma on a Down Day in the Market 04.15.13 | 01:04 pm
- Dow Today: Pfizer (PFE) Lower 04.15.13 | 01:04 pm
- Mad Money Uncovered: Merck and the Pharma Laggards
04.15.13 | 12:04 pm - Expect More Dividend Increases Like P&G 04.15.13 | 11:04 am
- Cramer's Top Stock Picks: FRT PFE K GIS 04.13.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 04.12.13 | 08:04 pm
Press Releases for PFE
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Pfizer’s BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From The European Commission - Business Wire 03.28.13 | 03:03 am
- Pfizer Invites Public To View And Listen To Webcast Of April 30 Conference Call With Analysts - Business Wire 03.26.13 | 10:03 am
- XELJANZ® (tofacitinib Citrate) Approved In Japan For The Treatment Of Adults With Rheumatoid Arthritis (RA) - Business Wire 03.25.13 | 07:03 am
- New Trial Results Support Treatment With Inspra (eplerenone) Within First 24 Hours Of Symptoms, In Addition To Standard Therapy, In Patients With Acute STEMI Without Heart Failure. - Business Wire 03.10.13 | 02:03 pm
- United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex® (celecoxib Capsules) - Business Wire 03.05.13 | 09:03 am
- Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevnar 13® In Adults With HIV - Business Wire 03.04.13 | 04:03 pm
- Top-Line Data Show Lyrica Met Primary Endpoint In Clinical Trial As Adjunctive Therapy Versus Levetiracetam In Patients With Partial Onset Seizures - Business Wire 02.21.13 | 08:02 am
- Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference - Business Wire 02.19.13 | 11:02 am
- Pfizer Inc. Issues Statement On ZoetisTM IPO - Business Wire 02.01.13 | 09:02 am
Partner Headlines for PFE
- Companies slide $181B through tax loopholes - MSN Money 04.19.13 | 10:04 am
- Thursday's BioPharma Trade Movers - Seeking Alpha 04.18.13 | 09:04 am
- Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for April 18, 2013 - NASDAQ 04.17.13 | 01:04 pm
- Cyclacel Pharmaceuticals, Inc. (CYCCP) Ex-Dividend Date Scheduled for April 17, 2013 - NASDAQ 04.16.13 | 01:04 pm
- Stocks Off Lows, Trade Mixed; Gold, Oil And Silver Unravel - Investor's Business Daily 04.15.13 | 12:04 pm
- Needed: Cure for soaring cost of medical school - MSN Money 04.15.13 | 12:04 am
- Pfizer’s Big Breakthrough for Breast Cancer - Wall St. Cheat Sheet 04.13.13 | 05:04 am
- Two drug giants spending less to woo doctors - MSN Money 04.12.13 | 01:04 pm
- Market Close Report: NASDAQ Composite index closes at 3,300.16 up 2.91 points - NASDAQ 04.11.13 | 08:04 pm
- Parexel Grows Earnings With Big Pharma Partnerships - Investor's Business Daily 04.04.13 | 02:04 pm
